Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of V221 (ProQuad) Concomitant with Prevnar in Children
NCT00109343Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Mar 2006
- Primary completion
- Sep 2007
- Modality
- Live Attenuated Vaccines
01
Overview
A Phase 3 trial of varicella virus vaccine live in measles, mumps, rubella, varicella (VZV), sponsored by Merck & Co.. Started Mar 2006; status: completed.
02
Drugs
varicella virus vaccine live
03
Conditions
measlesmumpsrubellavaricella (VZV)
Beyond the preview
Go deeper on NCT00109343.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00109343.